Warning letter
Glint Cosmetics Pvt Ltd: warning letter of May 31, 2019
FDA warning letter 573468 · Center for Drug Evaluation and Research
Key facts
| Reference number | 573468 |
|---|---|
| Company | Glint Cosmetics Pvt Ltd |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved/Misbranded |
| Issue date | May 31, 2019 |
| Posted date | Jun 11, 2019 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 201.61, 201.128, 211.22, 330.1, 341, 341.20, 211.67(a), 211.68(b), 341.40(u), 341.74(d)(2)(ii) |
| Inspection city | Navi Mumbai |
| Inspection start date | Dec 17, 2018 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: